drugset / Trial / NCT02690727
To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single centre, open label, randomized, two-treatment, two-period, two-sequence, single dose crossover food effect study in 18 subjects. The subjects will receive the study medication under either fed or fast during each treatment period.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenalisib | Small molecule | — | Oral |
Indications
No indication recorded.